by:

*NEW* Research Funding Opportunity

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Purpose: The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This limited competition Notice of Funding Opportunity (NOFO) invites investigator-initiated applications from institutions to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.

Funding Opportunity Number: PAR-25-296

Mechanism: UG3/UH3 Exploratory/Developmental Phased Award Cooperative Agreement

First due date: February 19, 2025

Expiration date: October 20, 2027

Technical Assistance Webinar: January 14^th, 2025, at 3:00 pm ET. Please see Notice for more information (NOT-TR-25-004).

Notice of Information: Technical Assistance Webinar for PAR-25-296: “Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)”